Showing results (361-370 of 532) with videos related to
Sort By:
Pageof 54
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study GroupR N Jones, K C Kugler, M E Erwin, et al.Diagnostic Microbiology and Infectious Disease|February 1, 1993
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeW W Hoover, E H Gerlach, D J Hoban, et al.Journal of Clinical Microbiology|August 7, 2009
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller, S A Messer, R J Hollis, et al.Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.The Journal of Thoracic and Cardiovascular Surgery|June 1, 1990
Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroximeB N Doebbeling, M A Pfaller, K R Kuhns, et al.Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.Archives of Internal Medicine|July 11, 1994
Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriageB N Doebbeling, D R Reagan, M A Pfaller, et al.Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.Diagnostic Microbiology and Infectious Disease|January 1, 1993
Value of the Hybritech ICON Candida Assay in the diagnosis of invasive candidiasis in high-risk patientsM A Pfaller, I Cabezudo, B Buschelman, et al.Pageof 54